Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhizopus arrhizus var. arrhizus
- Development stage
- Unknown
01
Overview
Rhizopus arrhizus var. arrhizus is a variety of the fungus *Rhizopus arrhizus*, which is a prevalent opportunist causing human infections, particularly mucormycosis. It is also widely applied in the food industry and biotechnology for fermenting traditional foods and producing organic acids and hydrolytic enzymes. Furthermore, it is classified as a non-standardized fungal allergenic extract, used for its physiological effects on the immune system.
- Other names
- R. oryzae
Beyond the preview
Go deeper on Rhizopus arrhizus var. arrhizus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rhizopus arrhizus var. arrhizus.